NewslettersCancer Stem Cell NewsExtracellular Matrix NewsHepatic Cell News Immune Activation of the Monocyte-Derived Dendritic Cells Using Patients Own Circulating Tumor Cells By Ishira - May 4, 2022 0 New protocols for monocyte-derived dendritic cell (mMo-DC) production using automatization and circulating tumor cell lysates were introduced including a feasible in vitro assay for mMo-DC efficacy evaluation. [Cancer Immunology Immunotherapy] Abstract